Skip to main content
. 2020 Jun 1;27(6):611–619. doi: 10.5551/jat.52084

Table 2. Baseline characteristics for all subjects according to CAVI status.

CAVI
p-value
< 8 8–8.9 ≥ 9
(n = 46) (n = 82) (n = 224)
Age (years) 57.3 ± 10.2 64.6 ± 8.2 71.2 ± 8.8 < 0.001
Male (N, %) 26 (56.5) 43 (52.4) 144 (64.3) 0.144
Body mass index (kg/m2) 27.8 ± 3.6 26.6 ± 4.1 24.8 ± 3.4 < 0.001
Type 2 diabetes (N, %) 30 (65.2) 45 (54.9) 144 (64.3) 0.292
Hypertension (N, %) 46 (100) 82 (100) 214 (95.5) 0.053
Chronic kidney disease (N, %) 25 (54.4) 49 (59.8) 126 (56.3) 0.806
Dyslipidemia (N, %) 43 (93.5) 76 (92.7) 209 (93.3) 0.978
Current smoking (N, %) 0 2 (2.4) 1 (0.5) 0.194
Systolic blood pressure (mmHg) 131.5 ± 15.6 136.3 ± 18.6 138.9 ± 15.0 0.015
Diastolic blood pressure (mmHg) 73.3 ± 9.5 75.7 ± 11.2 73.0 ± 9.9 0.115
Fasting plasma glucose (mg/dL) 130 ± 43.2 118.9 ± 40.3 128.4 ± 39.7 0.169
HemoglobinA1C (%) 7.0 ± 1.6 6.8 ± 1.4 6.9 ± 1.5 0.794
Cholesterol (mg/dL) 163.8 ± 35.3 168.9 ± 44.1 162.1 ± 39.9 0.454
Triglyceride (mg/dL) 124.4 ± 66.6 133.4 ± 86.7 124.7 ± 55.7 0.592
HDL cholesterol (mg/dL) 51.6 ± 12.2 53.5 ± 18.1 52.5 ± 15.1 0.797
LDL cholesterol (mg/dL) 97.9 ± 29.3 97.8 ± 33.6 93.2 ± 29.9 0.399
Estimated GFR (mL/min/1.73 m2) 54.2 ± 33.1 51.6 ± 31.7 50.4 ± 27.9 0.724
Median decline of estimated GFR (mL/min/1.73 m2 per year) −0.6 (−3.4 to 4) −0.7 (−7.5 to −0.13) −2.4 (−7.5 to −0.4) 0.003

CAVI; Cardio-ankle vascular index, GFR; Glomerular filtration rate